Acquiring Company
Crown Equipment
Acquired Company
QIAGEN
OhioManufacturingBiotechnologyHealth CareScience And EngineeringInternet ServicesDescription
Crown NL Bidco B.V. has announced a voluntary public takeover offer for QIAGEN N.V. The offer proposes a cash consideration of EUR 46.50 per share. Following the agreement, QIAGEN's boards have committed to support the takeover. If approved, the offer will give Crown full ownership of QIAGEN.
Who to call at Crown Equipment, and when
When Crown Equipment changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Crown Equipment raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Crown Equipment, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Crown Equipment makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired QIAGEN?
QIAGEN was acquired by Crown Equipment, based in Ohio. The deal was reported on October 21, 2026. Crown is one of the world’s largest material handling companies with a reputation for award-winning product design, advanced engineering and technology, and superior after-sale service. Crown Equipment is privately held and operates in Manufacturing.
When did Crown Equipment acquire QIAGEN?
Crown Equipment's acquisition of QIAGEN was reported on October 21, 2026. Crown NL Bidco B.V. has announced a voluntary public takeover offer for QIAGEN N.V. The offer proposes a cash consideration of EUR 46.50 per share. Following the agreement, QIAGEN's boards have committed to support the takeover. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does QIAGEN do?
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.